The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2968146
WO Application Number:
US2014029907
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14764361.3
WO Publication Number:
WO2014145187
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Taiwan, Chinese Taipei (TW)
Publications:
Dates
Filing date:
15/03/2014
Grant date:
19/02/2020
EP Publication Date:
20/01/2016
WO Publication Date:
18/09/2014
Claims Translations Received Date:
Claims Translation B1 Received Date:
10/03/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
19/02/2020
EP B1 Publication Date:
19/02/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/03/2034
Lapsed By Expiration Date:
Patent Validated Date:
27/03/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
19/02/2020
Name:
Taiwan Liposome Company, Ltd.
Address:
2F 3 Yuanqu Street
Nangang District, Taipei City 11503, Taiwan, Chinese Taipei (TW)
From:
19/02/2020
Name:
TLC Biopharmaceuticals, Inc.
Address:
611 Gateway Blvd., Suite 830, South San Francisco CA 94080, United States of America (US)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
25/03/2020
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)